vs
NEXSTAR MEDIA GROUP, INC.（NXST）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是NEXSTAR MEDIA GROUP, INC.的1.2倍（$1.5B vs $1.3B），Steris净利率更高（12.9% vs -12.9%，领先25.8%），Steris同比增速更快（9.2% vs -13.4%），Steris自由现金流更多（$199.5M vs $136.0M），过去两年Steris的营收复合增速更高（15.8% vs 0.2%）
Nexstar Media Group, Inc.是美国上市传媒企业，总部设于得克萨斯州欧文、曼哈顿中城及芝加哥，1996年6月17日成立。作为美国规模最大的电视台运营商，集团在全美共拥有197家电视台，多数为美国四大广播电视网及MyNetworkTV附属台，覆盖从纽约到得州圣安杰洛等不同规模的市场。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
NXST vs STE — 直观对比
营收规模更大
STE
是对方的1.2倍
$1.3B
营收增速更快
STE
高出22.6%
-13.4%
净利率更高
STE
高出25.8%
-12.9%
自由现金流更多
STE
多$63.5M
$136.0M
两年增速更快
STE
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.5B |
| 净利润 | $-166.0M | $192.9M |
| 毛利率 | — | 43.8% |
| 营业利润率 | 18.7% | 18.3% |
| 净利率 | -12.9% | 12.9% |
| 营收同比 | -13.4% | 9.2% |
| 净利润同比 | -168.6% | 11.2% |
| 每股收益（稀释后） | $-5.57 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NXSTSTE
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.2B | $1.5B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.5B | $1.4B | ||
| Q3 24 | $1.4B | $1.3B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.3B | $1.1B |
净利润NXSTSTE
| Q4 25 | $-166.0M | $192.9M | ||
| Q3 25 | $70.0M | $191.9M | ||
| Q2 25 | $97.0M | $177.4M | ||
| Q1 25 | $108.0M | $145.7M | ||
| Q4 24 | $242.0M | $173.5M | ||
| Q3 24 | $187.0M | $150.0M | ||
| Q2 24 | $118.0M | $145.4M | ||
| Q1 24 | $175.0M | $-1.4M |
毛利率NXSTSTE
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 44.2% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 43.6% | ||
| Q2 24 | — | 44.7% | ||
| Q1 24 | — | 40.2% |
营业利润率NXSTSTE
| Q4 25 | 18.7% | 18.3% | ||
| Q3 25 | 14.6% | 18.2% | ||
| Q2 25 | 17.3% | 17.7% | ||
| Q1 25 | 17.8% | 14.6% | ||
| Q4 24 | 28.1% | 17.9% | ||
| Q3 24 | 24.5% | 16.5% | ||
| Q2 24 | 18.9% | 14.5% | ||
| Q1 24 | 21.4% | 22.0% |
净利率NXSTSTE
| Q4 25 | -12.9% | 12.9% | ||
| Q3 25 | 5.8% | 13.1% | ||
| Q2 25 | 7.9% | 12.8% | ||
| Q1 25 | 8.8% | 9.8% | ||
| Q4 24 | 16.3% | 12.7% | ||
| Q3 24 | 13.7% | 11.3% | ||
| Q2 24 | 9.3% | 11.4% | ||
| Q1 24 | 13.6% | -0.1% |
每股收益（稀释后）NXSTSTE
| Q4 25 | $-5.57 | $1.96 | ||
| Q3 25 | $2.14 | $1.94 | ||
| Q2 25 | $3.06 | $1.79 | ||
| Q1 25 | $3.37 | $1.48 | ||
| Q4 24 | $7.44 | $1.75 | ||
| Q3 24 | $5.27 | $1.51 | ||
| Q2 24 | $3.54 | $1.46 | ||
| Q1 24 | $5.16 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $280.0M | $423.7M |
| 总债务越低越好 | $6.3B | $1.9B |
| 股东权益账面价值 | $2.1B | $7.2B |
| 总资产 | $10.8B | $10.6B |
| 负债/权益比越低杠杆越低 | 3.07× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资NXSTSTE
| Q4 25 | $280.0M | $423.7M | ||
| Q3 25 | $236.0M | $319.2M | ||
| Q2 25 | $234.0M | $279.7M | ||
| Q1 25 | $253.0M | $171.7M | ||
| Q4 24 | $144.0M | $155.2M | ||
| Q3 24 | $181.0M | $172.2M | ||
| Q2 24 | $146.0M | $198.3M | ||
| Q1 24 | $237.0M | $207.0M |
总债务NXSTSTE
| Q4 25 | $6.3B | $1.9B | ||
| Q3 25 | $6.4B | $1.9B | ||
| Q2 25 | $6.4B | $1.9B | ||
| Q1 25 | $6.5B | $1.9B | ||
| Q4 24 | $6.5B | $2.0B | ||
| Q3 24 | $6.7B | $2.2B | ||
| Q2 24 | $6.8B | $2.2B | ||
| Q1 24 | $6.8B | $3.1B |
股东权益NXSTSTE
| Q4 25 | $2.1B | $7.2B | ||
| Q3 25 | $2.3B | $7.0B | ||
| Q2 25 | $2.3B | $7.0B | ||
| Q1 25 | $2.2B | $6.6B | ||
| Q4 24 | $2.3B | $6.4B | ||
| Q3 24 | $2.2B | $6.6B | ||
| Q2 24 | $2.3B | $6.4B | ||
| Q1 24 | $2.3B | $6.3B |
总资产NXSTSTE
| Q4 25 | $10.8B | $10.6B | ||
| Q3 25 | $11.2B | $10.4B | ||
| Q2 25 | $11.3B | $10.4B | ||
| Q1 25 | $11.4B | $10.1B | ||
| Q4 24 | $11.5B | $10.0B | ||
| Q3 24 | $11.7B | $10.2B | ||
| Q2 24 | $11.8B | $10.1B | ||
| Q1 24 | $11.9B | $11.1B |
负债/权益比NXSTSTE
| Q4 25 | 3.07× | 0.27× | ||
| Q3 25 | 2.78× | 0.27× | ||
| Q2 25 | 2.83× | 0.27× | ||
| Q1 25 | 2.89× | 0.29× | ||
| Q4 24 | 2.89× | 0.32× | ||
| Q3 24 | 3.02× | 0.33× | ||
| Q2 24 | 2.99× | 0.35× | ||
| Q1 24 | 2.93× | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $190.0M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $136.0M | $199.5M |
| 自由现金流率自由现金流/营收 | 10.6% | 13.3% |
| 资本支出强度资本支出/营收 | 4.2% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | $743.0M | $917.1M |
8季度趋势，按日历期对齐
经营现金流NXSTSTE
| Q4 25 | $190.0M | $298.2M | ||
| Q3 25 | $117.0M | $287.8M | ||
| Q2 25 | $247.0M | $420.0M | ||
| Q1 25 | $337.0M | $260.8M | ||
| Q4 24 | $411.0M | $332.8M | ||
| Q3 24 | $387.0M | $250.7M | ||
| Q2 24 | $176.0M | $303.7M | ||
| Q1 24 | $276.0M | $254.8M |
自由现金流NXSTSTE
| Q4 25 | $136.0M | $199.5M | ||
| Q3 25 | $87.0M | $201.3M | ||
| Q2 25 | $218.0M | $326.4M | ||
| Q1 25 | $302.0M | $189.9M | ||
| Q4 24 | $376.0M | $243.6M | ||
| Q3 24 | $358.0M | $148.8M | ||
| Q2 24 | $139.0M | $195.7M | ||
| Q1 24 | $232.0M | $163.3M |
自由现金流率NXSTSTE
| Q4 25 | 10.6% | 13.3% | ||
| Q3 25 | 7.3% | 13.8% | ||
| Q2 25 | 17.7% | 23.5% | ||
| Q1 25 | 24.5% | 12.8% | ||
| Q4 24 | 25.3% | 17.8% | ||
| Q3 24 | 26.2% | 11.2% | ||
| Q2 24 | 11.0% | 15.3% | ||
| Q1 24 | 18.1% | 14.6% |
资本支出强度NXSTSTE
| Q4 25 | 4.2% | 6.6% | ||
| Q3 25 | 2.5% | 5.9% | ||
| Q2 25 | 2.4% | 6.7% | ||
| Q1 25 | 2.8% | 4.8% | ||
| Q4 24 | 2.4% | 6.5% | ||
| Q3 24 | 2.1% | 7.7% | ||
| Q2 24 | 2.9% | 8.4% | ||
| Q1 24 | 3.4% | 8.2% |
现金转化率NXSTSTE
| Q4 25 | — | 1.55× | ||
| Q3 25 | 1.67× | 1.50× | ||
| Q2 25 | 2.55× | 2.37× | ||
| Q1 25 | 3.12× | 1.79× | ||
| Q4 24 | 1.70× | 1.92× | ||
| Q3 24 | 2.07× | 1.67× | ||
| Q2 24 | 1.49× | 2.09× | ||
| Q1 24 | 1.58× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NXST
| Distribution Service | $704.0M | 55% |
| Advertising | $491.0M | 38% |
| Other | $78.0M | 6% |
| Corporate | $3.0M | 0% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
